• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

合成肽在内脏利什曼病自然宿主中引发强烈的细胞免疫,并有助于在BALB/c小鼠中产生持久的多功能T细胞。

Synthetic Peptides Elicit Strong Cellular Immunity in Visceral Leishmaniasis Natural Reservoir and Contribute to Long-Lasting Polyfunctional T-Cells in BALB/c Mice.

作者信息

De Brito Rory Cristiane Fortes, Cardoso Jamille Mirelle de Oliveira, Reis Levi Eduardo Soares, Mathias Fernando Augusto Siqueira, Aguiar-Soares Rodrigo Dian de Oliveira, Teixeira-Carvalho Andréa, Roatt Bruno Mendes, Corrêa-Oliveira Rodrigo, Ruiz Jeronimo Conceição, Resende Daniela de Melo, Reis Alexandre Barbosa

机构信息

Laboratório de Imunopatologia, Núcleo de Pesquisas em Ciências Biológicas/NUPEB, Universidade Federal de Ouro Preto, 35400-00 Ouro Preto, Minas Gerais, Brazil.

Laboratório Multiusuário de Citometria de Fluxo, Núcleo de Pesquisas em Ciências Biológicas/NUPEB, Universidade Federal de Ouro Preto, 35400-00 Ouro Preto, Minas Gerais, Brazil.

出版信息

Vaccines (Basel). 2019 Oct 28;7(4):162. doi: 10.3390/vaccines7040162.

DOI:10.3390/vaccines7040162
PMID:31661776
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6963447/
Abstract

Reverse vaccinology or immunoinformatics is a computational methodology which integrates data from in silico epitope prediction, associated to other important information as, for example, the predicted subcellular location of the proteins used in the design of the context of vaccine development. This approach has the potential to search for new targets for vaccine development in the predicted proteome of pathogenic organisms. To date, there is no effective vaccine employed in vaccination campaigns against visceral leishmaniasis (VL). For the first time, herein, an in silico, in vitro, and in vivo peptide screening was performed, and immunogenic peptides were selected to constitute VL peptide-based vaccines. Firstly, the screening of in silico potential peptides using dogs naturally infected by was conducted and the peptides with the best performance were selected. The mentioned peptides were used to compose Cockt-1 (cocktail 1) and Cockt-2 (cocktail 2) in combination with saponin as the adjuvant. Therefore, tests for immunogenicity, polyfunctional T-cells, and the ability to induce central and effector memory in T-lymphocytes capacity in reducing the parasite load on the spleen for Cockt-1 and Cockt-2 were performed. Among the vaccines under study, Cockt-1 showed the best results, eliciting CD4 and CD8 polyfunctional T-cells, with a reduction in spleen parasitism that correlates to the generation of T CD4 central memory and T CD8 effector memory cells. In this way, our findings corroborate the use of immunoinformatics as a tool for the development of future vaccines against VL.

摘要

反向疫苗学或免疫信息学是一种计算方法,它整合了来自计算机模拟表位预测的数据,并与其他重要信息相关联,例如在疫苗开发背景下设计中所使用蛋白质的预测亚细胞定位。这种方法有潜力在致病生物体的预测蛋白质组中寻找疫苗开发的新靶点。迄今为止,在针对内脏利什曼病(VL)的疫苗接种运动中尚未使用有效的疫苗。在此,首次进行了计算机模拟、体外和体内肽筛选,并选择了免疫原性肽来构成基于VL肽的疫苗。首先,对自然感染的犬进行了计算机模拟潜在肽的筛选,并选择了性能最佳的肽。上述肽与皂苷作为佐剂组合用于组成Cockt-1(鸡尾酒1)和Cockt-2(鸡尾酒2)。因此,对Cockt-1和Cockt-2进行了免疫原性、多功能T细胞以及诱导T淋巴细胞中中央记忆和效应记忆能力以降低脾脏寄生虫负荷的测试。在所研究的疫苗中,Cockt-1显示出最佳结果,引发了CD4和CD8多功能T细胞,脾脏寄生虫感染减少,这与T CD4中央记忆和T CD8效应记忆细胞的产生相关。通过这种方式,我们的研究结果证实了免疫信息学作为开发未来抗VL疫苗工具的用途。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/301f/6963447/8edff5b96c65/vaccines-07-00162-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/301f/6963447/a6068f9b7715/vaccines-07-00162-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/301f/6963447/761d76d5a777/vaccines-07-00162-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/301f/6963447/8955bf19728e/vaccines-07-00162-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/301f/6963447/83dbb8dcbae6/vaccines-07-00162-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/301f/6963447/8edff5b96c65/vaccines-07-00162-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/301f/6963447/a6068f9b7715/vaccines-07-00162-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/301f/6963447/761d76d5a777/vaccines-07-00162-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/301f/6963447/8955bf19728e/vaccines-07-00162-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/301f/6963447/83dbb8dcbae6/vaccines-07-00162-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/301f/6963447/8edff5b96c65/vaccines-07-00162-g005.jpg

相似文献

1
Synthetic Peptides Elicit Strong Cellular Immunity in Visceral Leishmaniasis Natural Reservoir and Contribute to Long-Lasting Polyfunctional T-Cells in BALB/c Mice.合成肽在内脏利什曼病自然宿主中引发强烈的细胞免疫,并有助于在BALB/c小鼠中产生持久的多功能T细胞。
Vaccines (Basel). 2019 Oct 28;7(4):162. doi: 10.3390/vaccines7040162.
2
Chimeric Vaccines Designed by Immunoinformatics-Activated Polyfunctional and Memory T Cells That Trigger Protection against Experimental Visceral Leishmaniasis.通过免疫信息学设计的嵌合疫苗激活多功能和记忆性T细胞,引发针对实验性内脏利什曼病的保护作用。
Vaccines (Basel). 2020 May 27;8(2):252. doi: 10.3390/vaccines8020252.
3
A Canine-Directed Chimeric Multi-Epitope Vaccine Induced Protective Immune Responses in BALB/c Mice Infected with .一种犬源导向的嵌合多表位疫苗在感染……的BALB/c小鼠中诱导了保护性免疫反应。
Vaccines (Basel). 2020 Jun 30;8(3):350. doi: 10.3390/vaccines8030350.
4
Identification of Potential MHC Class-II-Restricted Epitopes Derived from Antigens by Reverse Vaccinology and Evaluation of Their CD4+ T-Cell Responsiveness against Visceral Leishmaniasis.通过反向疫苗学鉴定源自抗原的潜在MHC-II类限制性表位及其针对内脏利什曼病的CD4 + T细胞反应性评估
Front Immunol. 2017 Dec 14;8:1763. doi: 10.3389/fimmu.2017.01763. eCollection 2017.
5
A Leishmania-specific hypothetical protein expressed in both promastigote and amastigote stages of Leishmania infantum employed for the serodiagnosis of, and as a vaccine candidate against, visceral leishmaniasis.一种在婴儿利什曼原虫的前鞭毛体和无鞭毛体阶段均表达的利什曼原虫特异性假设蛋白,用于内脏利什曼病的血清学诊断及作为候选疫苗。
Parasit Vectors. 2015 Jul 11;8:363. doi: 10.1186/s13071-015-0964-5.
6
An immunoinformatic approach driven by experimental proteomics: in silico design of a subunit candidate vaccine targeting secretory proteins of Leishmania donovani amastigotes.基于实验蛋白质组学的免疫信息学方法:针对利什曼原虫无鞭毛体分泌蛋白的亚单位候选疫苗的计算机设计。
Parasit Vectors. 2020 Apr 15;13(1):196. doi: 10.1186/s13071-020-04064-8.
7
A Poly(Lactic--Glycolic) Acid Nanovaccine Based on Chimeric Peptides from Different Proteins Induces Dendritic Cells Maturation and Promotes Peptide-Specific IFNγ-Producing CD8 T Cells Essential for the Protection against Experimental Visceral Leishmaniasis.一种基于不同蛋白质嵌合肽的聚(乳酸-乙醇酸)纳米疫苗可诱导树突状细胞成熟,并促进产生肽特异性干扰素γ的CD8 T细胞,这些细胞对于预防实验性内脏利什曼病至关重要。
Front Immunol. 2017 Jun 13;8:684. doi: 10.3389/fimmu.2017.00684. eCollection 2017.
8
Vaccination with poly(D,L-lactide-co-glycolide) nanoparticles loaded with soluble antigens and modified with a TNFα-mimicking peptide or monophosphoryl lipid A confers protection against experimental visceral leishmaniasis.用负载可溶性抗原并经肿瘤坏死因子α模拟肽或单磷酰脂质A修饰的聚(D,L-丙交酯-共-乙交酯)纳米颗粒进行疫苗接种可提供针对实验性内脏利什曼病的保护。
Int J Nanomedicine. 2017 Aug 23;12:6169-6184. doi: 10.2147/IJN.S141069. eCollection 2017.
9
Heterologous priming-boosting with DNA and vaccinia virus expressing kinetoplastid membrane protein-11 induces potent cellular immune response and confers protection against infection with antimony resistant and sensitive strains of Leishmania (Leishmania) donovani.用表达动基体膜蛋白-11 的 DNA 和痘苗病毒进行异源初免-加强免疫可诱导强烈的细胞免疫应答,并对感染耐锑和敏感株利什曼原虫(利什曼原虫) Donovan 具有保护作用。
Vaccine. 2013 Apr 8;31(15):1905-15. doi: 10.1016/j.vaccine.2013.02.025. Epub 2013 Feb 26.
10
Immunoinformatics-aided design of a potential multi-epitope peptide vaccine against Leishmania infantum.免疫信息学辅助设计针对利什曼原虫的潜在多表位肽疫苗。
Int J Biol Macromol. 2018 Dec;120(Pt A):1127-1139. doi: 10.1016/j.ijbiomac.2018.08.125. Epub 2018 Aug 30.

引用本文的文献

1
The development and maintenance of immunity against visceral leishmaniasis.针对内脏利什曼病免疫力的发展与维持。
Front Immunol. 2024 Dec 9;15:1486407. doi: 10.3389/fimmu.2024.1486407. eCollection 2024.
2
Efficacy of vaccines based on chimeric or multiepitope antigens for protection against visceral leishmaniasis: A systematic review.基于嵌合或多表位抗原的疫苗预防内脏利什曼病的疗效:一项系统评价。
PLoS Negl Trop Dis. 2024 Dec 31;18(12):e0012757. doi: 10.1371/journal.pntd.0012757. eCollection 2024 Dec.
3
A review of CD4 T cell differentiation and diversity in dogs.

本文引用的文献

1
NH36 and F3 Antigen-Primed Dendritic Cells Show Preserved Migrating Capabilities and CCR7 Expression and F3 Is Effective in Immunotherapy of Visceral Leishmaniasis.NH36 和 F3 抗原致敏树突状细胞保持迁移能力和 CCR7 表达,F3 可有效用于内脏利什曼病的免疫治疗。
Front Immunol. 2018 May 7;9:967. doi: 10.3389/fimmu.2018.00967. eCollection 2018.
2
Vaccine candidates against leishmania under current research.当前研究中的利什曼原虫疫苗候选物。
Expert Rev Vaccines. 2018 Apr;17(4):323-334. doi: 10.1080/14760584.2018.1459191. Epub 2018 Apr 10.
3
Liposomal Elongation Factor-1α Triggers Effector CD4 and CD8 T Cells for Induction of Long-Lasting Protective Immunity against Visceral Leishmaniasis.
犬类CD4 T细胞分化与多样性综述。
Vet Immunol Immunopathol. 2024 Sep;275:110816. doi: 10.1016/j.vetimm.2024.110816. Epub 2024 Aug 21.
4
Intramuscular Immunization with a Liposomal Multi-Epitope Chimeric Protein Induces Strong Cellular Immune Responses against Visceral Leishmaniasis.用脂质体多表位嵌合蛋白进行肌肉内免疫可诱导针对内脏利什曼病的强烈细胞免疫反应。
Vaccines (Basel). 2023 Aug 19;11(8):1384. doi: 10.3390/vaccines11081384.
5
The Use of an Adjuvant System Improves Innate and Adaptive Immune Response When Associated with a () Antigen in a Vaccine Candidate against () Infection.当与一种候选疫苗中的()抗原联合使用时,佐剂系统的应用可改善针对()感染的先天性和适应性免疫反应。
Vaccines (Basel). 2023 Feb 9;11(2):395. doi: 10.3390/vaccines11020395.
6
An Overview of Current Uses and Future Opportunities for Computer-Assisted Design of Vaccines for Neglected Tropical Diseases.被忽视热带病疫苗的计算机辅助设计的当前应用及未来机遇概述
Adv Appl Bioinform Chem. 2021 Feb 15;14:25-47. doi: 10.2147/AABC.S258759. eCollection 2021.
7
Liver infusion tryptose (LIT): the best choice for growth, viability, and infectivity of Leishmania infantum parasites.肝浸液胰蛋白胨(LIT):是提高婴儿利什曼原虫生长、活力和感染力的最佳选择。
Parasitol Res. 2020 Dec;119(12):4185-4195. doi: 10.1007/s00436-020-06893-z. Epub 2020 Oct 9.
8
Epitope Selection for Fighting Visceral Leishmaniosis: Not All Peptides Function the Same Way.对抗内脏利什曼病的表位选择:并非所有肽都以相同方式起作用。
Vaccines (Basel). 2020 Jul 1;8(3):352. doi: 10.3390/vaccines8030352.
9
A Canine-Directed Chimeric Multi-Epitope Vaccine Induced Protective Immune Responses in BALB/c Mice Infected with .一种犬源导向的嵌合多表位疫苗在感染……的BALB/c小鼠中诱导了保护性免疫反应。
Vaccines (Basel). 2020 Jun 30;8(3):350. doi: 10.3390/vaccines8030350.
10
Liposomal Formulation of ChimeraT, a Multiple T-Cell Epitope-Containing Recombinant Protein, Is a Candidate Vaccine for Human Visceral Leishmaniasis.含多种T细胞表位的重组蛋白ChimeraT的脂质体制剂是人类内脏利什曼病的候选疫苗。
Vaccines (Basel). 2020 Jun 9;8(2):289. doi: 10.3390/vaccines8020289.
脂质体延伸因子 1α 触发效应性 CD4 和 CD8 T 细胞,诱导针对内脏利什曼病的持久保护性免疫。
Front Immunol. 2018 Jan 30;9:18. doi: 10.3389/fimmu.2018.00018. eCollection 2018.
4
Identification of Potential MHC Class-II-Restricted Epitopes Derived from Antigens by Reverse Vaccinology and Evaluation of Their CD4+ T-Cell Responsiveness against Visceral Leishmaniasis.通过反向疫苗学鉴定源自抗原的潜在MHC-II类限制性表位及其针对内脏利什曼病的CD4 + T细胞反应性评估
Front Immunol. 2017 Dec 14;8:1763. doi: 10.3389/fimmu.2017.01763. eCollection 2017.
5
Selection strategy of phage-displayed immunogens based on an in vitro evaluation of the Th1 response of PBMCs and their potential use as a vaccine against Leishmania infantum infection.基于 PBMCs 的 Th1 反应的体外评估选择噬菌体展示免疫原的策略及其作为抗婴儿利什曼原虫感染疫苗的潜在用途。
Parasit Vectors. 2017 Dec 21;10(1):617. doi: 10.1186/s13071-017-2576-8.
6
Live Attenuated Centrin Gene-Deleted Parasites Induce IL-23-Dependent IL-17-Protective Immune Response against Visceral Leishmaniasis in a Murine Model.减毒活的中心体基因缺失寄生虫在小鼠模型中诱导产生依赖白细胞介素-23的白细胞介素-17保护性免疫反应,以抵抗内脏利什曼病。
J Immunol. 2018 Jan 1;200(1):163-176. doi: 10.4049/jimmunol.1700674. Epub 2017 Nov 29.
7
Vaccination with poly(D,L-lactide-co-glycolide) nanoparticles loaded with soluble antigens and modified with a TNFα-mimicking peptide or monophosphoryl lipid A confers protection against experimental visceral leishmaniasis.用负载可溶性抗原并经肿瘤坏死因子α模拟肽或单磷酰脂质A修饰的聚(D,L-丙交酯-共-乙交酯)纳米颗粒进行疫苗接种可提供针对实验性内脏利什曼病的保护。
Int J Nanomedicine. 2017 Aug 23;12:6169-6184. doi: 10.2147/IJN.S141069. eCollection 2017.
8
Mixed Formulation of Conventional and Pegylated Meglumine Antimoniate-Containing Liposomes Reduces Inflammatory Process and Parasite Burden in Leishmania infantum-Infected BALB/c Mice.常规和聚乙二醇化两性霉素 B 脂质体的混合配方可减少利什曼原虫感染 BALB/c 小鼠的炎症反应和寄生虫负担。
Antimicrob Agents Chemother. 2017 Oct 24;61(11). doi: 10.1128/AAC.00962-17. Print 2017 Nov.
9
Association between mast cells, tissue remodelation and parasite burden in the skin of dogs with visceral leishmaniasis.内脏利什曼病犬皮肤中肥大细胞、组织重塑与寄生虫负荷之间的关联。
Vet Parasitol. 2017 Aug 30;243:260-266. doi: 10.1016/j.vetpar.2017.05.028. Epub 2017 Jul 9.
10
A Poly(Lactic--Glycolic) Acid Nanovaccine Based on Chimeric Peptides from Different Proteins Induces Dendritic Cells Maturation and Promotes Peptide-Specific IFNγ-Producing CD8 T Cells Essential for the Protection against Experimental Visceral Leishmaniasis.一种基于不同蛋白质嵌合肽的聚(乳酸-乙醇酸)纳米疫苗可诱导树突状细胞成熟,并促进产生肽特异性干扰素γ的CD8 T细胞,这些细胞对于预防实验性内脏利什曼病至关重要。
Front Immunol. 2017 Jun 13;8:684. doi: 10.3389/fimmu.2017.00684. eCollection 2017.